|
|
||||||||
GENETICS |
,1
,1
,1











* Department of Poultry Science, University of Arkansas, Fayetteville 72701;
Poultry Production and Product Safety Research Unit, USDA-ARS, Fayetteville, AR 72701;
State Research Center for Applied Microbiology, Obolensk, Russian Federation; and
Poultry Microbiological Safety Research Unit, Russell Research Center, USDA-ARS, Athens, GA 30604
3 Corresponding author: ddonogh{at}uark.edu
Campylobacter is a leading cause of foodborne illness in the United States. Recent evidence has demonstrated that bacteriocins produced by Bacillus circulans and Paenibacillus polymyxa reduce cecal Campylobacter colonization in broiler chickens infected with Campylobacter jejuni. As Campylobacter coli is the most prevalent Campylobacter isolate recovered in turkeys, the objectives of the present study were to evaluate the efficacy of these bacteriocins against C. coli colonization and their influence on the gastrointestinal architecture of young turkeys. In 3 separate trials, a total of 135 day-of-hatch poults (n = 45/trial) were orally challenged on d 3 with approximately 106 cfu of a mixture of 3 C. coli isolates. Immediately before bacteriocin treatment (d 10), cecal Campylobacter concentrations averaged 1.1 x 107 cfu/ g of cecal contents (n = 15/trial). On d 10 to 12 posthatch, 2 bacteriocin treatment groups were given free access to feed supplemented with purified, microencapsulated bacteriocins, whereas the positive control treatment group had access to untreated feed (n = 10/treatment group per trial). At the end of the 3-d dosing period, ceca and duodenal loops were collected for analysis. In each of the 3 separate trials, treatment with bacteriocin eliminated detectable ceca Campylobacter concentrations (detection limit, 1 x 102 cfu/g of cecal contents) vs. controls (1.0 x 106 cfu of Campylobacter/g of cecal contents). Duodenum crypt depth and goblet cell numbers were also reduced in turkeys treated with either bacteriocin vs. controls (P < 0.05). The dynamic reduction in crypt depth and goblet cell density in turkeys dosed with bacteriocin may provide clues to how bacteriocins inhibit enteric Campylobacter.
Key Words: Campylobacter ceca bacteriocin turkey gastrointestinal tract
1 Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee or warranty by the USDA and does not imply its approval to the exclusion of other products that may be suitable.
2 This research has been supported in part by the Food Safety Consortium, the US Department of State (Washington, DC), the Russian Federation State Research Center for Applied Microbiology (Moscow, Russian Federation), the USDA-ARS, and the International Science and Technology Center project no. 1720.
This article has been cited by other articles:
![]() |
S. A. Sirsat, A. Muthaiyan, and S. C. Ricke Antimicrobials for foodborne pathogen reduction in organic and natural poultry production J. Appl. Poult. Res., January 1, 2009; 18(2): 379 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. de los Santos, A. M. Donoghue, K. Venkitanarayanan, J. H. Metcalf, I. Reyes-Herrera, M. L. Dirain, V. F. Aguiar, P. J. Blore, and D. J. Donoghue The natural feed additive caprylic acid decreases Campylobacter jejuni colonization in market-aged broiler chickens Poult. Sci., January 1, 2009; 88(1): 61 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. de los Santos, A. M. Donoghue, K. Venkitanarayanan, I. Reyes-Herrera, J. H. Metcalf, M. L. Dirain, V. F. Aguiar, P. J. Blore, and D. J. Donoghue Therapeutic Supplementation of Caprylic Acid in Feed Reduces Campylobacter jejuni Colonization in Broiler Chicks Appl. Envir. Microbiol., July 15, 2008; 74(14): 4564 - 4566. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. de los Santos, A. M. Donoghue, K. Venkitanarayanan, M. L. Dirain, I. Reyes-Herrera, P. J. Blore, and D. J. Donoghue Caprylic Acid Supplemented in Feed Reduces Enteric Campylobacter jejuni Colonization in Ten-Day-Old Broiler Chickens, Poult. Sci., April 1, 2008; 87(4): 800 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Line, E. A. Svetoch, B. V. Eruslanov, V. V. Perelygin, E. V. Mitsevich, I. P. Mitsevich, V. P. Levchuk, O. E. Svetoch, B. S. Seal, G. R. Siragusa, et al. Isolation and Purification of Enterocin E-760 with Broad Antimicrobial Activity against Gram-Positive and Gram-Negative Bacteria Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1094 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Cutler, S. M. Lonergan, N. Cornick, A. K. Johnson, and C. H. Stahl Dietary Inclusion of Colicin E1 Is Effective in Preventing Postweaning Diarrhea Caused by F18-Positive Escherichia coli in Pigs Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3830 - 3835. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Gardiner, M. C. Rea, B. O'Riordan, P. O'Connor, S. M. Morgan, P. G. Lawlor, P. B. Lynch, M. Cronin, R. P. Ross, and C. Hill Fate of the Two-Component Lantibiotic Lacticin 3147 in the Gastrointestinal Tract Appl. Envir. Microbiol., November 1, 2007; 73(21): 7103 - 7109. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |